European Companies Search Engine

27 EU fundings (total €11.9M): The Changing Nature of Employment in Europe in the Context of Challenges, Threats and Opportunities for Employees and Employers … BdlYear 2012 Financial Transparency System

Text

Siren 923376545

01/10/2012 EU funding (€1,012,800): FP7-SME-2012-315640 Helicovaxor Development of an Oral Helicobacter Pylori Vaccine.
01/02/2012 EU funding (€1,690,465): `Filming¿ Excited State Structural Dynamics in Photosynthesis and Organic Semiconductors
26/09/2012 EU funding (€1,970,893): From Health Research to Market ¿ Advanced Services and Training Actions for the IPR Management and Business Exploitation of the EU-Funded Research Results in Health/Life Sciences
01/11/2012 EU funding (€12M): Metagenomics in Cardiometabolic Diseases
01/08/2012 EU funding (€139,213): Pief-GA-2011-299441-Halochiral ( Asymmetric Halogenation of Olefins Involving Intermolecular Nucleophiles)
15/04/2012 EU funding (€139,213): Pief-GA-2011-302422-Halophore ( Development of Reporter Tools for an Improved Understanding of Pharmacophoreproteininteraction)
01/09/2012 EU funding (€2,148,403): Low Emission AntiFouling Coatings Based on the Novel Discovered Post Settlement Penetration Triggered Antifouling
01/09/2012 EU funding (€2,231,732): Development of Tools and Techniques to Survey, Assess, Stabilise, Monitor and Preserve Underwater Archaeological Sites
01/02/2012 EU funding (€2,615,500): FP7-SME-2011-286903-Nephrops:Development of New Techniques in Hatchery Rearing, Fishery Enhancement and Aquaculture for Nephrops
01/01/2012 EU funding (€2,886,757): Developing Single Cell Technologies for Systems Biology
01/09/2012 EU funding (€2,999,263): Improving the Organisation of Maternal Health Service Delivery, and Optimising Childbirth, by Increasing Vaginal Birth After Caesarean Section (Vbac) through Enhanced Women-Centred Care
01/05/2012 EU funding (€241,042): Role of Gene Silencing Pathways in C. Elegans Nicotine Dependence
01/07/2012 EU funding (€250,483): Synergistic Modeling of Gene-Brain Couplings with Applications in Affective Neuroscience
01/04/2012 EU funding (€259,065): Pief-GA-2010-272348- Alpha Cancer Therapy - Targeted Conformal Radiotherapy of Disseminated Cancers, Using the Alpha-Particle Emitting Radionuclides Astatine-211, Bismuth-213 and Actinium-225.
01/11/2012 EU funding (€3,137,774): *****
01/01/2012 EU funding (€3,332,852): Design AS Driver of Innovation and Competitiveness
01/12/2012 EU funding (€3,973,086): The Changing Nature of Employment in Europe in the Context of Challenges, Threats and Opportunities for Employees and Employers
01/06/2012 EU funding (€3,987,796): GA 289066 SFS - SP4-Capacities - FP7-Science-in-Society-2011-1 - SIS.2011.1.0-1 - SEA for Society
11/09/2012 EU funding (€358,327): The Role of Mitochondrial DNA Double-Strand Break Repair in Human Disease and Normal Ageing
01/08/2012 EU funding (€4,314,641): 312455 Isbe
21/08/2012 EU funding (€475,000): Varieties of Democracy (V-dem)
01/01/2012 EU funding (€5,678,487): GA 283646 - Dasish - FP7-Infrastructures-2011-1 - Infra-2011-2.3.1. - SP4-Capacities
01/01/2012 EU funding (€5,831,949): A European Multicentre Double-Blind Placebo-Controlled Phase III Trial of nilvadIpine in Mild to Moderate Alzheimer¿s Disease
01/10/2012 EU funding (€5,990,236): New Approach to Treatment of the Blinding Disease Retinopathy of Prematurity (ROP)
01/01/2012 EU funding (€563,016): GA 288985 Serscida - FP7-SIS.2011.1.3.1.-1. - SP4 Capacities
01/03/2012 EU funding (€7,940,984): GA 290529 Anticorrp SP1-Cooperation - Collaborative Project - Large Scfale Integrating Project FP7-SSH-2011-1 - SSH.2011.5.1-1
01/03/2012 EU funding (€9,000,000): Determinants of Eating Behaviour in European Children, Adolescents and Their Parents

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Göteborgs universitet Statliga enheter, 405 30 Goteborg, Sweden.